project id: TCGA-TGCT; case submitter id: TCGA-ZM-AA0N; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.9; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 0.71; rna integrity number: 7.7; age at index: 44; days to birth: -16094; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1969; age at diagnosis: 16094; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IB; ajcc clinical t: T2; ajcc pathologic m: M0; ajcc pathologic n: NX; ajcc pathologic stage: Stage IB; ajcc pathologic t: T2; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 634.0; icd 10 code: C62.9; last known disease status: not reported; morphology: 9061/3; primary diagnosis: Seminoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Testis, NOS; synchronous malignancy: No; tissue or organ of origin: Testis, NOS; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 191; days to sample procurement: 0; initial weight: 290.0; portion submitter id: TCGA-ZM-AA0N-01A-21; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 75.0;